Variables | Total | Initial risk | P-values | ||
---|---|---|---|---|---|
Low (n=104) | Intermediate (n=71) | High (n=55) | |||
Follow-up (years), median (Q1, Q3) | 4.6 (2.7, 7.4) | 5.2 (3.0, 8.0) | 4.6 (2.3, 7.0) | 3.5 (2.5, 5.1) | 0.01 |
Outcome at last visit | |||||
Excellent response | 142 (61.7) | 81 (77.9) | 47 (66.2) | 14 (25.5) | <0.0001 |
Indetermined response | 32 (13.9) | 16 (15.4) | 7 (9.9) | 9 (16.4) | |
Biochemically incomplete | 24 (10.4) | 4 (3.8) | 10 (14.1) | 10 (18.2) | |
Structurally incomplete | 32 (13.9) | 3 (2.9) | 7 (9.9) | 22 (40.0) | |
Death related to thyroid cancer | |||||
Alive | 222 (96.5) | 103 (99.0) | 71 (100) | 48 (87.3) | 0.0003 |
Yes | 6 (2.6) | 0 (0.0) | 0 (0.0) | 6 (10.9) | |
no | 2 (0.9) | 1 (1.0) | 0 (0.0) | 1 (1.8) |
Values are presented as numbers and precentages (%) or median (first quartile [Q1], third quartile [Q3]).